Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 35 announcements

Share price: ₹826.50
Market cap: ₹13,009 Cr
Revenue (annual): ₹4,359 Cr
Net profit (annual): ₹255.2 Cr
P/E (TTM): 44.6×Sector 47.4×
Promoter holding: 75.26%+0.00% QoQ
FII holding: 1.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 7 Earnings Call 5 Legal & Regulatory 4 Financial Results 4 Adverse Business Impact 3 Results Update 2 Management Change 2 Board Meeting Date 2 Merger & Restructuring 1 Fund Raise 1 Credit Rating 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

11 Apr 2026 17:35 IST BSE

Credit Rating

Akums Drugs & Pharmaceuticals Credit Rating

Akums Drugs and Pharmaceuticals Limited received credit rating updates from ICRA for Rs. 285 Crore in facilities. ICRA reaffirmed the [ICRA]AA (Stable)/[ICRA]A1+ rating for Rs. 85 Crore in working capital limits and assigned a new [ICRA]A1+ rating to a Rs. 200 Crore commercial paper programme, reflecting a strong liquidity position.

Value: ₹285.0 Cr

Read the filing ↗